We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+2.36%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$26.2B
AUM Growth
+$914M
(+3.6%)
Cap. Flow
+$1.01B
Cap. Flow
% of AUM
3.87%
Top 10 Holdings %
Top 10 Hldgs %
32.55%
Holding
1,591
New
69
Increased
817
Reduced
431
Closed
49
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$107M |
| 2 |
EXL Service
EXLS
|
+$72M |
| 3 |
Apple
AAPL
|
+$64.3M |
| 4 |
Synopsys
SNPS
|
+$56.8M |
| 5 |
ServiceNow
NOW
|
+$54.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$74.5M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$53.5M |
| 3 |
Edwards Lifesciences
EW
|
+$45M |
| 4 |
Abbott
ABT
|
+$40.3M |
| 5 |
Rockwell Automation
ROK
|
+$39.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.4% |
| 2 | Healthcare | 16.63% |
| 3 | Financials | 12.04% |
| 4 | Communication Services | 9.47% |
| 5 | Industrials | 8.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Cognex
CGNX
$10.4B
| $1.63M | 0.01% |
45,500
+5,800
| +15% | +$227K |
|
752
AXIS Capital
AXS
$7.3B
| $1.63M | 0.01% |
18,400
+2,600
| +16% | +$223K |
|
753
Shift4
FOUR
$3.79B
| $1.63M | 0.01% |
15,700
+2,300
| +17% | +$228K |
|
|
BPMC
754
DELISTED
Blueprint Medicines
BPMC
| $1.63M | 0.01% |
18,651
+3,000
| +19% | +$275K |
|
755
Watts Water Technologies
WTS
$12.8B
| $1.61M | 0.01% |
7,944
+800
| +11% | +$166K |
|
756
Element Solutions
ESI
$9.51B
| $1.61M | 0.01% |
63,415
| – | – |
|
757
RH
RH
$3.4B
| $1.61M | 0.01% |
4,096
-3,500
| -46% | -$1.24M |
|
758
A.O. Smith
AOS
$8.49B
| $1.6M | 0.01% |
23,500
+18,129
| +338% | +$1.37M |
|
759
Vontier
VNT
$4.47B
| $1.6M | 0.01% |
43,900
+4,900
| +13% | +$181K |
|
760
MGIC Investment
MTG
$6.33B
| $1.6M | 0.01% |
67,482
+7,000
| +12% | +$175K |
|
761
Dutch Bros
BROS
$8.93B
| $1.6M | 0.01% |
30,500
+7,200
| +31% | +$318K |
|
762
Five Below
FIVE
$13.4B
| $1.6M | 0.01% |
15,209
+2,200
| +17% | +$210K |
|
763
Commault Systems
CVLT
$6.26B
| $1.59M | 0.01% |
10,530
+1,600
| +18% | +$257K |
|
764
Toro Company
TTC
$9.21B
| $1.59M | 0.01% |
19,839
| – | – |
|
765
UFP Industries
UFPI
$5.03B
| $1.59M | 0.01% |
14,095
+1,400
| +11% | +$180K |
|
766
Doximity
DOCS
$4.74B
| $1.59M | 0.01% |
29,700
+200
| +0.7% | +$9.79K |
|
767
Group 1 Automotive
GPI
$3.14B
| $1.58M | 0.01% |
3,758
-300
| -7% | -$119K |
|
768
Zurn Elkay Water Solutions
ZWS
$8.41B
| $1.58M | 0.01% |
42,418
-6,700
| -14% | -$255K |
|
769
Phillips Edison & Co
PECO
$5.2B
| $1.58M | 0.01% |
42,100
+1,400
| +3% | +$53.3K |
|
770
First American
FAF
$7.56B
| $1.56M | 0.01% |
25,060
+1,700
| +7% | +$111K |
|
771
Mattel
MAT
$4.25B
| $1.56M | 0.01% |
88,200
| – | – |
|
772
Mohawk Industries
MHK
$9.42B
| $1.56M | 0.01% |
13,111
-1,400
| -10% | -$196K |
|
773
Rithm Capital
RITM
$5.79B
| $1.56M | 0.01% |
143,994
+20,800
| +17% | +$225K |
|
774
Inspire Medical Systems
INSP
$1.68B
| $1.56M | 0.01% |
8,400
| – | – |
|
|
COOP
775
DELISTED
Mr. Cooper
COOP
| $1.55M | 0.01% |
16,200
-700
| -4% | -$66.5K |
|
Similar funds
GAM
Handelsbanken Fonder's Q4 2024 Portfolio in Review
As of Q4 2024, Handelsbanken Fonder held 1,591 positions worth $26.2B, up 3.6% from $25.3B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder deployed $1.01B of net new capital in Q4 2024, opening 69 new positions and adding to 817 existing holdings. Its largest new stake was GE Vernova: 105,537 shares worth $34.7M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Halozyme, an estimated $74.5M trimmed.
- Handelsbanken Fonder's largest Q4 2024 buy was GE Vernova: 105,537 shares worth $34.7M.
- Handelsbanken Fonder added most to Microsoft in Q4 2024, an estimated $107M increase.
- Handelsbanken Fonder's biggest Q4 2024 reduction was Halozyme, cutting an estimated $74.5M.
- Handelsbanken Fonder fully exited BeOne Medicines Ltd in Q4 2024, selling an estimated $5.92M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $26.2B portfolio in Q4 2024.
- Handelsbanken Fonder opened 69 new positions and closed 49 in Q4 2024.
- Handelsbanken Fonder's portfolio value rose 3.6% quarter-over-quarter to $26.2B.
Based on Handelsbanken Fonder's 13F filing for Q4 2024, filed 3 Feb 2025.